眼科用デバイスの世界市場2020–2027:製品機能別(外科用デバイス、診断装置、ビジョンケア機器)

◆英語タイトル:Ophthalmic Devices Market by Product Function [Surgical Devices (Refractive Error Surgery Devices, Glaucoma Surgery Devices, Cataract Surgery Devices, and Vitreoretinal Surgery Devices) Ophthalmic Diagnostic Devices (Refractors, Corneal Topography Systems, Retinal Ultrasound Systems, Fundus Camera, Ophthalmoscopes, OCT, Perimeters, Slit Lamps, and Tonometer), and Vision Care Devices (Contact Lenses and Spectacles)]: Global Opportunity Analysis and Industry Forecast, 2020–2027
◆商品コード:AMR20PL065
◆発行会社(リサーチ会社):Allied Market Research
◆発行日:2020年6月
◆ページ数:175
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,769 ⇒換算¥605,745見積依頼/購入/質問フォーム
5 UserUSD6,450 ⇒換算¥677,250見積依頼/購入/質問フォーム
Enterprise UserUSD8,995 ⇒換算¥944,475見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Allied Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、眼科用デバイスの世界市場について調査・分析することにより、イントロダクション、エグゼクティブサマリー、市場概要、製品機能別(外科用デバイス、診断装置、ビジョンケア機器)分析、地域別分析、企業情報など、今後の市場展望をまとめております。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・眼科用デバイスの世界市場規模:製品機能別(外科用デバイス、診断装置、ビジョンケア機器)
・眼科用デバイスの世界市場規模:地域別
・企業情報
【レポートの概要】

The global ophthalmic devices market was valued at $32,534.0 million in 2019, and is projected to reach $44,865.0 million by 2027, registering a CAGR of 4.0 % from 2020 to 2027.

Ophthalmology is a branch of medical science that deals with the structure, function, and various eye diseases. Ophthalmic devices are medical equipment designed for diagnosis, surgery, and vision correction. These devices are gaining increased importance and adoption due to surge in prevalence of various ophthalmic diseases such as glaucoma, cataract, and other vision-related issues.

The growth of the global ophthalmic devices market is majorly driven by rise in adoption of digital devices, including laptops, smartphones, and computers, e-readers; rapid technological advancements in ophthalmic devices such as intraocular lenses (IOLs) coupled with increasing focus on customer training and education for the use of ophthalmic devices which would help in building the staff skills; and surge in awareness related to devices used in ophthalmology. However, low awareness regarding eye-related diseases and dearth of skilled professionals are expected to hamper the growth of the market. Also, emerging countries such as China, India and other Asia-Pacific countries possess high growth potential, owing to the improving healthcare infrastructures in these countries.

Based on product function, the report segments the global ophthalmic devices market into ophthalmic surgical devices, diagnostic devices, and vision care devices. The ophthalmic surgical devices segment is further categorized into refractive error surgical devices, glaucoma surgical devices, cataract surgical devices, and vitreoretinal surgical devices. The cataract surgery devices segment dominated the ophthalmic surgical devices market in 2019, and is expected to reach $5,219.6 by 2017, registering a CAGR of 3.9% from 2020 to 2027.

The ophthalmic diagnostic devices segment is sub segmented into refractors, corneal topography systems, retinal ultrasound systems, fundus camera, ophthalmoscopes, optical coherence tomography systems, perimeters, slit lamps, and tonometer. The retinal ultrasound segment is expected to reach $3,286.6 by 2027, registering a CAGR of 4.4% from 2020 to 2027.

The vision care devices segment is bifurcated into contact lenses and spectacle lenses. The spectacle leases segment is expected to reach $12,669 by 2027, registering a CAGR of 3.6% from 2020 to 2027.
On a regional level, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America ophthalmic devices market accounted for the largest share; however, the Asia-Pacific region is anticipated to grow with the highest CAGR of 4.5% during the forecast period.

The global ophthalmology devices market is highly competitive in nature, as major players have focused on the development and launch of innovative products to garner maximum share in the competitive market. The key players operating in the market include Abbott Laboratories, Novartis AG, Carl Zeiss Meditec AG, Essilor International S.A., HAAG-Streit Holding AG, Johnson & Johnson, Nidek Co., Ltd., Topcon Corporation, Valeant Pharmaceuticals International, Inc., and Ziemer Ophthalmic Systems AG. The other players in the industry include Sonomed Escalon, Hoya Group, Gulden Ophthalmics, FCI Ophthalmics, Glaukos Corporation, and STAAR Surgical.

KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the global ophthalmic devices market size along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers market analysis from 2020 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
• A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global ophthalmic devices market growth.

KEY MARKET SEGMENTS
By Product Function
• Ophthalmic Surgical Devices
o Refractive Error Surgical Devices
o Glaucoma Surgical Devices
o Cataract Surgery Devices
o Vitreoretinal Surgical Devices
• Ophthalmic Diagnostic Devices
o Refractors
o Corneal Topography Systems
o Retinal Ultrasound Systems
o Fundus Camera
o Ophthalmoscopes
o Optical Coherence Tomography Systems
o Perimeters
o Slit Lamps
o Tonometer’s
• Ophthalmic Vision Care Devices
o Contact Lenses
o Spectacle Lenses

By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o Rest of Asia-Pacific
• LAMEA
o Brazil
o South Africa
o Saudi Arabia
o Rest of LAMEA

List of key players profiled in the report
• Novartis AG
• Carl Zeiss Meditec AG
• Essilor International S.A.
• HAAG-Streit Holding AG
• Johnson & Johnson
• Nidek Co., Ltd.
• Topcon Corporation
• Valeant Pharmaceuticals International, Inc.
• Ziemer Ophthalmic Systems AG
• Hoya Corporation

List of other players in the value chain (profiles not included in the report):
• Sonomed Escalon
• Gulden Ophthalmics
• FCI Ophthalmics
• Glaukos Corporation
• STAAR Surgical GE Healthcare (U.K.)

【レポートの目次】

CHAPTER 1: INTRODUCTION

1.1. Report description

1.1.1. Key benefits for stakeholders
1.1.2. Key market segments

1.2. Research methodology

1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top player positioning, 2019
3.2.3. Key forces shaping the global ophthalmic devices market

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Rise in prevalence of eye-related diseases worldwide
3.3.1.2. Rapid technological advancements in ophthalmic
3.3.1.3. Increase in focus on customer training and education along with awareness
3.3.1.4. High adoption of digital devices worldwide

3.3.2. Restraints

3.3.2.1. Low awareness about eye-related diseases
3.3.2.2. Dearth of skilled professionals53

3.3.3. Opportunities

3.3.3.1. Potential growth opportunities in emerging nations for ophthalmic devices manufacturers

3.4. GOVERNMENT REGULATIONS

3.4.1. FDA
3.4.2. CE Mark
3.4.3. Pharmaceuticals and Medical Devices Agency and Ministry of Health, Labor, and Welfare (MHLW)

CHAPTER 4: OPTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION

4.1. Overview

4.1.1. Market size and forecast, by region

4.2. Surgical devices

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Refractive error surgical devices

4.2.3.1. Market size and forecast

4.2.4. Glaucoma surgical devices

4.2.4.1. Market size and forecast

4.2.5. Cataract surgical devices

4.2.5.1. Market size and forecast

4.2.6. Vitreoretinal surgical devices

4.2.6.1. Market size and forecast

4.3. Diagnostic devices

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Refractors

4.3.3.1. Market size and forecast

4.3.4. Corneal topography systems

4.3.4.1. Market size and forecast

4.3.5. Retinal ultrasound systems

4.3.5.1. Market size and forecast

4.3.6. Fundus camera

4.3.6.1. Market size and forecast

4.3.7. Ophthalmoscopes

4.3.7.1. Market size and forecast

4.3.8. Optical coherence tomography systems

4.3.8.1. Market size and forecast

4.3.9. Perimeters

4.3.9.1. Market size and forecast

4.3.10. Slit lamps

4.3.10.1. Market size and forecast

4.3.11. Tonometer

4.3.11.1. Market size and forecast

4.4. Vision care devices

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Contact lenses

4.4.3.1. Market size and forecast

4.4.4. Spectacle lenses

4.4.4.1. Market size and forecast

CHAPTER 5: OPHTHALMIC DEVICES MARKET, BY REGION

5.1. Overview

5.1.1. Market size and forecast

5.2. North America

5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by product function
5.2.3. Market size and forecast, by region
5.2.4. U.S.

5.2.4.1. Market size and forecast, by product function

5.2.5. Canada

5.2.5.1. Market size and forecast, by product function

5.2.6. Mexico

5.2.6.1. Market size and forecast, by product function

5.3. Europe

5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by product function
5.3.3. Market size and forecast, by region
5.3.4. Germany

5.3.4.1. Market size and forecast, by product function

5.3.5. France

5.3.5.1. Market size and forecast, by product function

5.3.6. UK

5.3.6.1. Market size and forecast, by product function

5.3.7. Italy

5.3.7.1. Market size and forecast, by product function

5.3.8. Spain

5.3.8.1. Market size and forecast, by product function

5.3.9. Rest of the Europe

5.3.9.1. Market size and forecast, by product function

5.4. Asia-Pacific

5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by product function
5.4.3. Market size and forecast, by region
5.4.4. Japan

5.4.4.1. Market size and forecast, by product function

5.4.5. China

5.4.5.1. Market size and forecast, by product function
5.4.6. Australia market size and forecast
5.4.6.1. Market size and forecast, by product function

5.4.7. India

5.4.7.1. Market size and forecast, by product function

5.4.8. Rest of Asia-Pacific

5.4.8.1. Market size and forecast, by product function

5.5. LAMEA

5.5.1. Key market trends, growth factors, and opportunities
5.5.2. Market size and forecast, by product function
5.5.3. Market size and forecast, by region
5.5.4. Brazil

5.5.4.1. Market size and forecast, by product function

5.5.5. Saudi Arabia market size and forecast

5.5.5.1. Market size and forecast, by product function

5.5.6. South Africa

5.5.6.1. Market size and forecast, by product function

5.5.7. Rest of LAMEA

5.5.7.1. Market size and forecast, by product function

CHAPTER 6: COMPANY PROFILES

6.1. Carl Zeiss Meditec AG

6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Product portfolio
6.1.5. Business performance
6.1.6. Key strategic moves and developments

6.2. Essilor International S.A.

6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product portfolio
6.2.5. Business performance
6.2.6. Key strategic moves and developments

6.3. Haag-Streit holding Ag

6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments

6.4. Hoya Corporation

6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segments
6.4.4. Business performance
6.4.5. Key strategic moves and developments

6.5. Johnson & Johnson

6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.5.4. Product portfolio
6.5.5. Business performance
6.5.6. Key strategic moves and developments

6.6. NIDEK CO., LTD.

6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Key strategic moves & developments

6.7. Novartis AG (ALCON-a division of Novartis)

6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product portfolio
6.7.5. Business performance

6.8. Topcon Corporation

6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.8.4. Product portfolio
6.8.5. Business performance

6.9. Bausch Health Companies Inc.

6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Product portfolio
6.9.5. Business performance

6.10. Ziemer Ophthalmic Systems AG

6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Product portfolio

6.11. List of mergers and acquisitions (M&A) activities

LIST OF TABLES

TABLE 01. GLOBAL OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 02. OPHTHALMIC SURGICAL DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 03. OPHTHALMIC DIAGNOSTIC DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 04. OPHTHALMIC VISION CARE DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 05. OPHTHALMIC DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 06. NORTH AMERICA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 07. NORTH AMERICA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 08. U.S. OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 09. CANADA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 10. MEXICO OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 11. EUROPE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 12. EUROPE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 13. GERMANY OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 14. FRANCE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 15. UK OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 16. ITALY OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 17. SPAIN OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 18. REST OF EUROPE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 19. ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 20. ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 21. JAPAN OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 22. CHINA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 23. AUSTRALIA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 24. INDIA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 25. REST OF ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 26. LAMEA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 27. LAMEA OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 28. BRAZIL OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 29. SAUDI ARABIA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 30. SOUTH AFRICA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 31. REST OF LAMEA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 32. CARL ZEISS: COMPANY SNAPSHOT
TABLE 33. CARL ZEISS: OPERATING SEGMENTS
TABLE 34. CARL ZEISS: PRODUCT PORTFOLIO
TABLE 35. ESSILOR: COMPANY SNAPSHOT
TABLE 36. ESSILOR: OPERATING SEGMENTS
TABLE 37. ESSILOR: PRODUCT PORTFOLIO
TABLE 38. HAAG-STREIT: COMPANY SNAPSHOT
TABLE 39. HAAG-STREIT: OPERATING SEGMENTS
TABLE 40. HOYA: COMPANY SNAPSHOT
TABLE 41. HOYA: OPERATING SEGMENTS
TABLE 42. J&J: COMPANY SNAPSHOT
TABLE 43. J&J: OPERATING SEGMENTS
TABLE 44. J&J: PRODUCT PORTFOLIO
TABLE 45. NIDEK: COMPANY SNAPSHOT
TABLE 46. NIDEK: OPERATING SEGMENTS
TABLE 47. NOVARTIS: COMPANY SNAPSHOT
TABLE 48. NOVARTIS: OPERATING SEGMENTS
TABLE 49. NOVARTIS: PRODUCT PORTFOLIO
TABLE 50. TOPCON: COMPANY SNAPSHOT
TABLE 51. TOPCON: OPERATING SEGMENTS
TABLE 52. TOPCON: PRODUCT PORTFOLIO
TABLE 53. BAUSCH HEALTH COMPANIES: COMPANY SNAPSHOT
TABLE 54. BAUSCH HEALTH COMPANIES : OPERATING SEGMENTS
TABLE 55. BAUSCH HEALTH COMPANIES: PRODUCT PORTFOLIO
TABLE 56. ZEIMER: COMPANY SNAPSHOT
TABLE 57. ZIEMER: PRODUCT PORTFOLIO

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[眼科用デバイスの世界市場2020–2027:製品機能別(外科用デバイス、診断装置、ビジョンケア機器)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆